Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1994 Mar;69(3):599–600. doi: 10.1038/bjc.1994.110

The phase of the menstrual cycle has no influence on the disease-free survival of patients with mammary carcinoma.

T Wobbes 1, C M Thomas 1, M F Segers 1, P G Peer 1, E D Bruggink 1, L V Beex 1
PMCID: PMC1968874  PMID: 8123495

Abstract

We evaluated the outcome of treatment for mammary carcinoma in 89 premenopausal women in relation to the phase of the menstrual cycle. The phase of the cycle was determined on the basis of serum concentrations of 17 beta-oestradiol and progesterone. The serum samples were collected 1 day prior to or on the day of operation. After a median follow-up of 4.1 years no significant differences in disease-free survival were found between the preovulatory (proliferative), periovulatory and post-ovulatory (luteal) groups. No differences in survival were found in these subgroups between the N0 and N1 subgroup. On the basis of this study we cannot confirm that the phase of the menstrual cycle during surgery has any effect on the eventual outcome in mammary carcinoma patients. However larger studies of this type are required before definitive conclusions can be reached.

Full text

PDF
599

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Badwe R. A., Gregory W. M., Chaudary M. A., Richards M. A., Bentley A. E., Rubens R. D., Fentiman I. S. Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer. Lancet. 1991 May 25;337(8752):1261–1264. doi: 10.1016/0140-6736(91)92927-t. [DOI] [PubMed] [Google Scholar]
  2. Forbes J. F. Timing of breast cancer surgery in the menstrual cycle and outcome. Ann Oncol. 1991 Apr;2(4):243–243. doi: 10.1093/oxfordjournals.annonc.a057926. [DOI] [PubMed] [Google Scholar]
  3. Gnant M. F., Seifert M., Jakesz R., Adler A., Mittlboeck M., Sevelda P. Breast cancer and timing of surgery during menstrual cycle. A 5-year analysis of 385 pre-menopausal women. Int J Cancer. 1992 Nov 11;52(5):707–712. doi: 10.1002/ijc.2910520507. [DOI] [PubMed] [Google Scholar]
  4. Gregory W. M., Richards M. A., Fentiman I. S. Optimal timing of initial breast cancer surgery. Ann Intern Med. 1992 Feb 1;116(3):268–269. [PubMed] [Google Scholar]
  5. Gruber S. A., Nichol K. L., Sothern R. B., Malone M. E., Potter J. D., Lakatua D., Hrushesky W. J. Menstrual history and breast cancer surgery. Breast Cancer Res Treat. 1989 Jul;13(3):278–278. doi: 10.1007/BF02106578. [DOI] [PubMed] [Google Scholar]
  6. Hrushesky W. J., Bluming A. Z., Gruber S. A., Sothern R. B. Menstrual influence on surgical cure of breast cancer. Lancet. 1989 Oct 21;2(8669):949–952. doi: 10.1016/s0140-6736(89)90956-2. [DOI] [PubMed] [Google Scholar]
  7. Rageth J. C., Wyss P., Unger C., Hochuli E. Timing of breast cancer surgery within the menstrual cycle: influence on lymph-node involvement, receptor status, postoperative metastatic spread and local recurrence. Ann Oncol. 1991 Apr;2(4):269–272. doi: 10.1093/oxfordjournals.annonc.a057935. [DOI] [PubMed] [Google Scholar]
  8. Senie R. T., Rosen P. P., Rhodes P., Lesser M. L. Timing of breast cancer excision during the menstrual cycle influences duration of disease-free survival. Ann Intern Med. 1991 Sep 1;115(5):337–342. doi: 10.7326/0003-4819-115-5-337. [DOI] [PubMed] [Google Scholar]
  9. Thomas C. M., Corbey R. S., Rolland R. Assessment of unconjugated oestradiol and progesterone serum levels throughout pregnancy in normal women and in women with hyperprolactinaemia, who conceived after bromocriptine treatment. Acta Endocrinol (Copenh) 1977 Oct;86(2):405–414. doi: 10.1530/acta.0.0860405. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES